Project Number 5R01AG066627-02 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Early Stage Studies of a Novel Positive Allosteric Modulator of the Alpha1-Adrenergic Receptor to Treat Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator PEREZ, DIANNE M Principal Investigator First Name DIANNE M Principal Investigator Last Name PEREZ Awardee Organization CLEVELAND CLINIC LERNER COM-CWRU Awardee State Ohio Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-19-147: Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) FY Overall Cost $402,500 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official REFOLO, LORENZO
